Navigation Links
ImmunGene's Pipeline of Next Generation Cancer Therapeutics Featured in BioWorld Today
Date:11/11/2010

THOUSAND OAKS, Calif., Nov. 11, 2010 /PRNewswire/ -- ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that a profile of the company and its pipeline is featured in the November 21 issue of BioWorld Today in the NewCo section http://www.bioworld.com/.

The publication noted that, "ImmunGene is currently in advanced partnership discussion with several biotech and pharma companies for its payload... The firm's approach involves fusing a monoclonal antibody with a cytokine, initially interferon, for local delivery to the tumor. Called a CmAb, the molecule can be aimed 'directly where we want it to go,' (CEO Sanjay) Khare said."

The addition of the cytokine means that: "'...our CmAbs can do more [than other antibody arming ADCs] since select cytokines are associated with several desirable anti-tumor functions,' he said. CmAbs also are genetically engineered molecules, which could make them simpler and cheaper to produce. 'There's no multistep manufacturing process,' Khare added."

"Another benefit is that the CmAbs can be dosed at a very low level and still be efficacious. ImmunGene's researchers, for example, have been able to limit interferon activity in CmAb to one-one hundredth of the unfused IFN. By fusing it with an antibody that binds only to tumor cells, that interferon dose is sufficient to initiate cell death. ImmunGene's lead CmAb candidate, IGN002, is a third-generation antibody-fusion drug designed to target CD20-positive tumors, initially going after non-Hodgkin's lymphoma not treatable by Rituxan (rituximab, Genentech Inc./Roche AG and Biogen Idec Inc.)," noted the BioWorld article.

Dr. Sanjay Khare, ImmunGene's Chief Executive Officer said, "We are pleased to receive recognition from a global biotech publication for ImmunGene's pipeline of next genera
'/>"/>

SOURCE ImmunGene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Epratuzumab Phase IIb Data Presented at ACR Show Pipeline Drug had Positive Effect in Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus
2. Innovations and Opportunities in Therapeutic Vaccines: Technology Platforms, Key Players, and Early Pipeline Candidates
3. Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs
4. Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders
5. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
6. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial Results
7. Reportlinker Adds Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
8. Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports
9. Updated Pfizer Pipeline Focuses on Value, Unmet Medical Need
10. Reportlinker Adds Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
11. Reportlinker Adds Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... -- Concord Medical Services Holdings Limited ("Concord Medical" or ... specialty hospital management solution provider and operator of the ... China , today announced that on ... special cash dividend of US$0.30 per ordinary share (or ... outstanding ordinary shares. The total expense for the special ...
(Date:7/28/2014)... TOKYO , July 28, 2014 /PRNewswire/ ... appointed Roger Crystal , MD as Vice President ... the Global Business Development Product Acquisition & Licensing team ... in developing business strategy and partnerships in the precision ... to partner with biotechnology and pharmaceutical companies across the ...
(Date:7/28/2014)... , July 28, 2014   Cardioxyl Pharmaceuticals, ... clinical trial demonstrating that CXL-1427, a novel potential treatment ... in healthy volunteers. The company has now initiated dosing ... Phase IIa clinical trial designed to further evaluate the ... levels. The Phase I clinical trial evaluated ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2
... , CHICAGO , July 30 ... equity firm focused exclusively on health care, announced today ... (MSD).  Headquartered in Stoughton, Massachusetts , MSD ... biomedical services and technology solutions to the growing home ...
... , CATANIA, Italy , July 30 ... European research project today announced details of the ... three-year ENIAC (European Nanoelectronics Initiative Advisory Council) project ... 3D-imaging platforms by focusing on the diagnosis and ...
Cached Medicine Technology:Water Street Healthcare Partners Announces New Investment in Medical Specialties Distributors, LLC 2Water Street Healthcare Partners Announces New Investment in Medical Specialties Distributors, LLC 3Water Street Healthcare Partners Announces New Investment in Medical Specialties Distributors, LLC 4European Research Project Aims to Improve the Diagnosis and Therapy of Brain Diseases 2European Research Project Aims to Improve the Diagnosis and Therapy of Brain Diseases 3
(Date:7/28/2014)... brain was able to arouse animals receiving general anesthesia ... issue of Anesthesiology , investigators from Massachusetts General ... of either agent would move, raise their heads and ... to the ventral tegmental area (VTA). Stimulation of ... not induce the animals to wake up. , ...
(Date:7/28/2014)... The report, “Blowing Agents Market by Type, ... Forecasts to 2019” defines and segments the global ... the global consumption volume and value. , Browse ... figures spread through 226 Pages and in-depth TOC ... Blowing agents are highly utilized materials as a ...
(Date:7/28/2014)... test developed at University of Colorado Skaggs School of ... (July 28, 2014) An influential new test, discovered ... the CU School of Pharmacy, helps monitor the effectiveness ... of tenofovir/emtricitabine), which is taken once daily to prevent ... AIDS 2014 Conference and published in Lancet Infectious ...
(Date:7/28/2014)... Medicine (BUSM) report variants in a new gene, PLXNA4, ... (AD). The discovery of this novel genetic association may ... specifically. These findings appear in the Annals of ... dementia affecting 5.4 million Americans including 13 percent of ... percent of people age 85 and older. Genetic factors ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Recent research ... desk all day for years can lead to a ... cardiovascular disease. But using a standing desk, or an ... pain, often driving office workers back to a seated ... are designed to alleviate this leg pain and ...
Breaking Medicine News(10 mins):Health News:Stimulation of brain region restores consciousness to animals under general anesthesia 2Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 2Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 3Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 4Health News:HIV research findings made possible by a test developed at CU School of Pharmacy 2Health News:Researchers identify potential biomarker for AD 2Health News:New Standing Desk Anti-fatigue Mats from Martinson-Nicholls Reduce Leg Fatigue and Discomfort Working at Standing and Sit-to-Stand Desks 2
... Westchester, Ill. A study in the Oct. 1 issue of ... are associated with depression, suicide ideation and attempts, and the ... , Findings suggest that the presence of insomnia in ... also may increase the severity of these problems. Results indicate ...
... reliably predict whether they will adhere to physical ... in a new study. The findings could help ... preoperative preparation to ensure they attend therapy sessions ... that can greatly affect their long-term recovery. , ...
... save more than 1 million children, Stores raise funds ... 30 Quarters found in the,bottom of purses, pockets, and ... dying for needy children. The Vitamin Shoppe is asking,everyone to ... life of a,child., Affecting up to 140 million children ...
... Emergency Service,Center (DESC) is pleased to release its ... to store and manage information about clients,services and ... both proven and a work-in-progress, and has,been under ... CHASERS has been in continuous use, and now ...
... 31, New Episodes from MARTHA SPEAKS, SUPER WHY, WORDWORLD,and CYBERCHASE ... Think, To Prepare for the Long Holiday Season Ahead, ... Treats in Moderation, ARLINGTON, Va., Sept. 30 PBS ... exploring fears on Halloween,day and preparing for the holiday season ...
... of Oklahoma Health Sciences Center has created the first genetic research ... causes blindness. The research appears in a recent issue of the ... The team ... researchers from Harvard Medical School. The group is studying how diabetes ...
Cached Medicine News:Health News:Adolescent insomnia linked to depression and substance abuse during adolescence and young adulthood 2Health News:Will patients stick to physical therapy? Questionnaire can help doctors predict 2Health News:Will patients stick to physical therapy? Questionnaire can help doctors predict 3Health News:Spare Change Can Help Save the Life of a Child 2Health News:Spare Change Can Help Save the Life of a Child 3Health News:Downtown Emergency Service Center Releases CHASERS, Free Software for Homeless Service Management and Beyond 2Health News:Downtown Emergency Service Center Releases CHASERS, Free Software for Homeless Service Management and Beyond 3Health News:PBS KIDS(R) and PBS KIDS GO!(sm) Explore Halloween's Tricks and Treats 2Health News:PBS KIDS(R) and PBS KIDS GO!(sm) Explore Halloween's Tricks and Treats 3Health News:PBS KIDS(R) and PBS KIDS GO!(sm) Explore Halloween's Tricks and Treats 4Health News:PBS KIDS(R) and PBS KIDS GO!(sm) Explore Halloween's Tricks and Treats 5Health News:Researchers create first model for retina receptors 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: